Reported 2 days ago
Major pharmaceutical companies are urging the Trump administration and European Union to exempt medical goods from impending tariff wars, citing concerns that tariffs could lead to increased prices and reduced access to essential medications like Novo Nordisk's Wegovy and Merck's Keytruda. Executives from the industry have emphasized the interconnected nature of global supply chains and the potential harm to patients if tariffs result in price hikes. With the U.S. reliant on imports from Europe for critical medicines, the industry fears that escalating trade tensions could jeopardize healthcare access in America.
Source: YAHOO